New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
09:25 EDTRHT, NKE, CEMI, HALO, PFE, RIMM, WAG, TSPTOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Red Hat (RHT), up 5.4%... Nike (NKE), up 3%... ALSO HIGHER: Chembio Diagnostics (CEMI), up 20.7% after receiving FDA approval for its rapid HIV test... Halozyme (HALO), up 17.4% after entering a development collaboration with Pfizer (PFE)... Ameristar Casinos (ASCA), up 17% after agreeing to be acquired by Pinnacle Entertainment (PNK) for $26.50 per share... LOWER AFTER EARNINGS: Research in Motion (RIMM), down 16.3%... Walgreen (WAG), down 1.7%... ALSO LOWER: Transcept (TSPT), down 14.7% after Phase 2 trial of OCD drug misses primary endpoint.
News For RHT;NKE;CEMI;HALO;PFE;RIMM;WAG;TSPT From The Last 14 Days
Check below for free stories on RHT;NKE;CEMI;HALO;PFE;RIMM;WAG;TSPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 7, 2014
09:00 EDTPFEPfizer falls 2.8%
Pfizer is down 2.8%, or 90c, to $31.25
08:52 EDTCEMIChembio Diagnostics terminates U.S. distribution agreement with Alere
Subscribe for More Information
08:48 EDTRHTRed Hat underlying trends remain solid, says RW Baird at RW Baird
Subscribe for More Information
07:27 EDTPFEAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
April 6, 2014
13:46 EDTPFEPfizer's palbociclib significantly prolonged PFS in metastatic breast cancer
Subscribe for More Information
April 4, 2014
16:30 EDTHALOOn The Fly: Closing Wrap
Subscribe for More Information
12:09 EDTHALOOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTHALOHalozyme falls 27.5%
Subscribe for More Information
10:00 EDTHALOHalozyme falls 24.4%
Subscribe for More Information
09:37 EDTHALOHalozyme defended after halt of Phase 2 trial enrollment at Piper Jaffray
Subscribe for More Information
09:13 EDTHALOOn The Fly: Pre-market Movers
HIGHER: Mylan (MYL), up 6.8% after report of desire to buy Swedish rival Meda, which confirmed it had been in talks with Mylan but rejected the company's takeover offer. Shares of Mylan were also upgraded to Buy this morning at Citigroup... Mercury Systems (MRCY), up 8.8% after Reuters said Boeing (BA) is considering a takeover bid of the supplier..Micron (MU), up 3% after reporting earnings and revenue that topped expectations... Align (ALGN), up 6% after winning patent case against ClearCorrect... GameStop (GME), up 2.8% following upgrade at BofA Merrill Lynch... Potbelly (PBPB), up 4.6% after upgrade at William Blair.... SYNNEX (SNX), up 18.5% after earnings report. LOWER: CarMax (KMX), down 3.3% after reporting earnings and revenue that fell below expectations... Halozyme (HALO), down 33% after announcing temporary halt of Phase 2 trial enrollment for PEGPH20... Ocean Power (OPTT), down 15% after 3.8M share Spot Secondary priced at $3.10.
09:07 EDTHALOHalozyme volatility elevated into temporary halt of Phase 2 trial enrollment
Halozyme volatility is expected to move after announces temporary halt of Phase 2 trial enrollment for PEGPH20. Overall option implied volatility of 89 is above its 26-week average of 72 according to Track Data, suggesting large price movement.
09:00 EDTHALOHalozyme falls 31%
Halozyme is down 31%, or $3.59, to $8.00
08:03 EDTHALOHalozyme announces temporary halt of Phase 2 trial enrollment for PEGPH20
Subscribe for More Information
April 3, 2014
13:03 EDTWAGWalgreens signs definitive agreement with Water Street Healthcare Partners
Subscribe for More Information
11:36 EDTRHT Options with decreasing implied volatility: RH APOL BBRY VJET RHT
Subscribe for More Information
09:30 EDTPFEApple, Pfizer others create 'go slow' patent lobby group, Reuters says
Subscribe for More Information
08:27 EDTPFELeerink's biotech analyst holds a dinner meeting update
Biotech Analyst Liang holds an update from the AACR's Annual Meeting to discuss some of the presentations including PFE/AMGN's Palbociclib, PBYI/PFE's Neratinib, as well as other new agents for breast cancer from LLY, MDVN and CLDX, in San Diego on April 7 at 9 pm.
08:02 EDTWAGWalgreens reports March SSS up 3.5%, total Mach sales $6.43B
Subscribe for More Information
05:50 EDTPFEStocks with implied volatility movement; OXY PFE
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use